Open access · CC-BY
via OpenAlex
6711 Single Nuclei RNA-seq To Map Adipose Cellular Populations And Senescent Cells In Response To A Lifestyle Or Senolytic Intervention In Older Adults With Obesity: A Double-Blind, Placebo-Controlled, Randomized Trial
Arianne Aslamy, Gavin Connolly, Jia Nie, Sara E Espinoza, Monica C. Serra, Nicolas Musi
Journal of the Endocrine Society · 2024
Abstract
Abstract Disclosure: A. Aslamy: None. G. Connolly: None. J. Nie: None. S. Espinoza: None. M. Serra: None. N. Musi: None. It is well established that obese and older individuals are at significantly increased risk for diabetes and metabolic syndrome. However, the underlying molecular mechanisms by which increased adiposity and aging predisposes individuals to metabolic disease are not well understood. Recent data suggests that variations in adipocyte cellular populations and subpopulations influence whole body metabolism. Particularly, an increased burden of adipocyte senescent cells (cells that are in a state of replicative arrest) have been implicated in metabolic diseases. To investigate the relationship between adipose molecular signatures and cellular senescence(definition) on metabolic outcomes, we will use a novel, high-throughput, high-resolution methodology called single nuclei RNA sequencing (SnRNA-seq) to develop a transcriptomic atlas of human adipose tissue and analyze molecular profiles before and after interventions of lifestyle vs. senolytic vs. placebo. We will recruit a cohort of older obese participants (≥65 years of age; BMI = 30-39.9 kg/m2; n = 72), and conduct a double-blinded, placebo-controlled, randomized trial in which we obtain adipose biopsies to analyze cellular/molecular profiling via snRNA-seq as it relates to phenotypic measures of insulin sensitivity, glucose tolerance, beta cell function, and hepatic lipid content compared to cohorts of younger lean (18-30 years of age; BMI = 18.5-24.9 kg/m2; n = 24) and older lean (≥65 years of age; BMI = 18.5-24.9 kg/m2; n = 24) participants. Older obese participants will be randomized to one of three groups for a 10-week period: lifestyle (diet- and exercise-induced weight loss of 8-10% of body mass), senolytic (dasatinib and quercetin), or placebo. Repeat adipose biopsies and metabolic testing will be analyzed before and after intervention to assess potential changes in gene expression and associated phenotypic measures. Inclusion criteria for the older obese participants are the following: ≥65 years of age, BMI 30-39.9 kg/m2, any sex, race and ethnic group, sedentary (≤1.5h of exercise per week), and nondiabetic. Exclusion criteria include history of diabetes, participation in structured exercise >1.5h per week, chronic inflammatory/neurologic/autoimmune/pulmonary disorders, GI or heart disease, use of anti-arrhythmic or weight altering medications, smoking/alcohol use, previous bariatric surgery, and use of/allergy to senolytic agents. Preliminary snRNA-seq analyses of adipose biopsies from our pilot study with non-diabetic participants identified cells with elevated expression of positive regulators of senescence (CDKN1A, CDKN2A, ARG2); notably, one subpopulation of senescent adipocytes, termed NewA1, was increased with higher BMI. Overall, the findings from this study may help us gain better understanding of the aging process and identify potential molecular targets for prevention of metabolic disease. Presentation: 6/1/2024
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1210/jendso/bvae163.938
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Aslamy, A., Connolly, G., Nie, J., Espinoza, S.E., Serra, M.C., & Musi, N. (2024). 6711 Single Nuclei RNA-seq To Map Adipose Cellular Populations And Senescent Cells In Response To A Lifestyle Or Senolytic Intervention In Older Adults With Obesity: A Double-Blind, Placebo-Controlled, Randomized Trial. <em>Journal of the Endocrine Society</em>. https://doi.org/10.1210/jendso/bvae163.938
Vancouver
Aslamy A, Connolly G, Nie J, Espinoza SE, Serra MC, Musi N. 6711 Single Nuclei RNA-seq To Map Adipose Cellular Populations And Senescent Cells In Response To A Lifestyle Or Senolytic Intervention In Older Adults With Obesity: A Double-Blind, Placebo-Controlled, Randomized Trial. Journal of the Endocrine Society. 2024. doi:10.1210/jendso/bvae163.938.
BibTeX
@article{arianne2024Single,
title = {6711 Single Nuclei RNA-seq To Map Adipose Cellular Populations And Senescent Cells In Response To A Lifestyle Or Senolytic Intervention In Older Adults With Obesity: A Double-Blind, Placebo-Controlled, Randomized Trial},
author = {Arianne Aslamy and Gavin Connolly and Jia Nie and Sara E Espinoza and Monica C. Serra and Nicolas Musi},
journal = {Journal of the Endocrine Society},
year = {2024},
doi = {10.1210/jendso/bvae163.938},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes 2024
Citation only
10-PUB: Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Response to a Lifestyle or Senolytic Intervention in Older Adults with Obesity—A Double-Blind, Placebo-Controlled, Randomized Trial
Asia University 2020
Open access · US-GOV
Protein Supplementation Intervention for Improving Muscle Mass and Physical Performance in Older People With Sarcopenia: A Randomized, Double-blind, Placebo-controlled Trial
Wake Forest University Health Sciences 2011
Open access · US-GOV
Use of a Soy-based Meal Replacement Weight Loss Intervention to Impact Ectopic Fat and Associated Cardio-metabolic Risk in Obese, Older Adults: A Feasibility Study
Diabetes Care 2007
Open access · OA
Exercise Capacity and Cardiovascular/Metabolic Characteristics of Overweight and Obese Individuals With Type 2 Diabetes
University of Massachusetts, Amherst 2018
Open access · US-GOV
Sex-specific Adaptation to Different Resistance Exercise Programs in Older Adults
EBioMedicine 2025
Open access · CC-BY